// App-Quantinova.ai

: Linking the Anti‐inflammatory and Anticoagulant Properties, the Natural Inhibitor EcTI Impairs the Physiopathological Aspects of Thrombosis

Researchers

Presenter

  • B. Salu

Principal Investigators

  • M.V.d. Brito

  • J.W.M.C. Cruz

  • M.D.S. Araujo

  • F.H.A. Maffei

  • M.L.V. Oliva

Medical Centers

  • Federal University of São Paulo, Biochemistry, São Paulo, Brazil

  • University of the State of Minas Gerais, Passos, Brazil

  • São Paulo State University, Department of Surgery and Orthopedics, Botucatu, Brazil

Locations

  • Brazil

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Rose bengal sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved